![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro and NextWave Announce Agreement to Co-Promote OVIDE in the United States
31 juil. 2008 07h00 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y. and VERNON HILLS, Ill., July 31, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro" or the "Company") (Pink Sheets:TAROF) and NextWave Pharmaceuticals, Inc....
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Updates Shareholders On Financial Turnaround; Projects Significant Growth in Net Sales in 2008; Reaffirms Board's Recommendation Not to Tender Shares
28 juil. 2008 07h00 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., July 28, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company") (Pink Sheets:TAROF) today announced that it is sending a letter to its shareholders...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Provides Preliminary First Half 2008 Financial Results
23 juil. 2008 07h00 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., July 23, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company") (Pink Sheets:TAROF) today provided information on its financial performance for the first...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Board Concludes That Sun Tender Offer is Financially Inadequate, is a 'Sham' Offer and Violates Israeli Law
10 juil. 2008 07h00 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., July 10, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company") (Pink Sheets:TAROF) said today that its Board of Directors (with Drs. Barrie Levitt and...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Board of Directors to Evaluate Unsolicited Tender Offer From Sun Pharmaceutical Industries Ltd.
30 juin 2008 17h00 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., June 30, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro" or the "Company") (Pink Sheets:TAROF) said today that it would have no formal comment on the unsolicited...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Receives Final FDA Approval for Rx Cetirizine Hydrochloride Syrup ANDA
23 juin 2008 07h00 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., June 23, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. (Pink Sheets:TAROF) ("Taro", the "Company") reported today that it has received final approval from the U.S. Food...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Sends Letter to Update Shareholders On Latest Developments Regarding the Terminated Sun Merger Agreement
19 juin 2008 07h10 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., June 19, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. (Pink Sheets:TAROF) ("Taro" or the "Company") today announced that it is sending a letter to its shareholders...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Terminates Merger Agreement With Sun Pharmaceutical Industries Ltd.
28 mai 2008 07h00 HE
|
Taro Pharmaceutical Industries Ltd.
Taro Board Unanimously Rejects as Inadequate Sun's Revised
Offer of $10.25 Per Share
Significant Turnaround in Taro's Operating Performance;
Board...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Reaches Agreement in Principle to Settle Securities Lawsuit
28 avr. 2008 17h32 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., April 28, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company") (Pink Sheets:TAROF) announced today that the parties in the purported securities class...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Receives Final FDA Approval for Cetirizine Hydrochloride Oral Solution ANDA
22 avr. 2008 11h16 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., April 22, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. (Pink Sheets:TAROF) ("Taro", the "Company") reported today that it has received final approval from the U.S....